Literature DB >> 9229581

Isoprostanes--prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage.

J A Awad1, L J Roberts, R F Burk, J D Morrow.   

Abstract

F2-isoprostanes are prostanoids produced independently of cyclooxygenase by free radical-catalyzed peroxidation of arachidonic acid-containing lipids. Quantification of F2-isoprostanes from biologic fluids and tissues represents an important advance in the detection and measurement of lipid peroxidation in vivo. In addition, efforts to understand both the biophysical effects of isoprostane containing lipids and the biologic effects of free isoprostanes should lead to a better understanding of the mechanisms responsible for oxidant stress-related alterations in homeostasis. Continued application of F2-isoprostane measurement in experimental models of free radical-induced injury and human disease may allow better design and evaluation of antioxidant therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9229581     DOI: 10.1016/s0889-8553(05)70255-7

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  11 in total

1.  Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma.

Authors:  L G Wood; D A Fitzgerald; P G Gibson; D M Cooper; M L Garg
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs.

Authors:  Katherine M Kuniyoshi; Romy S Brock; Bisrat H Gebrekristos; Matthew Abad-Santos; Dinh Hoang; Houchang D Modanlou; Brigham C Willis; Kay D Beharry
Journal:  Am J Transl Res       Date:  2010-06-08       Impact factor: 4.060

Review 3.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

4.  Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis.

Authors:  C E Collins; P Quaggiotto; L Wood; E V O'Loughlin; R L Henry; M L Garg
Journal:  Lipids       Date:  1999-06       Impact factor: 1.880

5.  Nebivolol decreases systemic oxidative stress in healthy volunteers.

Authors:  R Troost; E Schwedhelm; S Rojczyk; D Tsikas; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

6.  Human temporomandibular joint and myofascial pain biochemical profiles: a case-control study.

Authors:  D L Basi; A M Velly; E L Schiffman; P A Lenton; D A Besspiata; A M Rankin; P J Hughes; J Q Swift; L J Kehl
Journal:  J Oral Rehabil       Date:  2012-01-17       Impact factor: 3.837

7.  Exogenous Superoxide Dismutase Mimetic Without Scavenging H2O2 Causes Photoreceptor Damage in a Rat Model for Oxygen-Induced Retinopathy.

Authors:  Shamin Jivabhai Patel; Fayez Bany-Mohammed; Lois McNally; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda; Kay D Beharry
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-10       Impact factor: 4.799

8.  A pilot study of total personal exposure to volatile organic compounds among Hispanic female domestic cleaners.

Authors:  Kelly Oyer-Peterson; David Gimeno Ruiz de Porras; Inkyu Han; George L Delclos; Edward G Brooks; Masoud Afshar; Kristina W Whitworth
Journal:  J Occup Environ Hyg       Date:  2022-01-28       Impact factor: 2.155

9.  Hydrogen peroxide accumulation in the choroid during intermittent hypoxia increases risk of severe oxygen-induced retinopathy in neonatal rats.

Authors:  Kay D Beharry; Charles L Cai; Poonam Sharma; Vadim Bronshtein; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-19       Impact factor: 4.799

10.  Timing of solid food introduction is associated with urinary F2-isoprostane concentrations in childhood.

Authors:  Brittni N Frederiksen; Jennifer Seifert; Miranda Kroehl; Molly M Lamb; Ginger L Milne; Marian Rewers; Jill M Norris
Journal:  Pediatr Res       Date:  2015-06-17       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.